A New Cold War?

For those of you who missed the Cold War and its 40 years of denunciations, mistrust, and calumny, it is difficult to understand what life was like in science during those times. Not the major affronts like the persecution of Sakharov and the ascendancy of Lysenko. It was the little things, like sending research letters to friends or wondering how to send journal subscriptions with any hope of their arrival, or the care package of pilfered Eppendorf tips and microtiter plates sent with travelers

Written byCecil Fox
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

For those of you who missed the Cold War and its 40 years of denunciations, mistrust, and calumny, it is difficult to understand what life was like in science during those times. Not the major affronts like the persecution of Sakharov and the ascendancy of Lysenko. It was the little things, like sending research letters to friends or wondering how to send journal subscriptions with any hope of their arrival, or the care package of pilfered Eppendorf tips and microtiter plates sent with travelers or even in "the Pouch."

Well, don't despair. Those times are still with us, courtesy of the US Treasury Department. The Office of Foreign Assets Control [OFAC] has decided that scientists in four nations cannot (yes, cannot) publish in American peer-reviewed journals.12 These measures, which exceed the Cold War in their excess, seem progressive in scope and are accompanied by threats of dire penalties and a ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies